NIMRAD – A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck Cancer

Research output: Contribution to journalArticlepeer-review

  • External authors:
  • D Thomson
  • H Yang
  • H Baines
  • E Miles
  • S Bolton
  • N Slevin

Bibliographical metadata

Original languageEnglish
Pages (from-to)344-347
Number of pages3
JournalClinical Oncology
Publication statusPublished - 2014